Molly Bonds
Nurse Practitioner · Huntsville, ALNPI 1790381143
Payments from drug & device makers
Across 66 payments — averaging $24.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$245
- Vifor Pharma, Inc.$197
- Novartis$187
- Fresenius USA Marketing, Inc.$147
- Akebia Therapeutics Inc$123
- Calliditas Therapeutics US Inc.$108
- plus $604 from 13 others
What the payments were for
- Food & beverage$1,610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $245 |
| Vifor Pharma, Inc. | 9 | $197 |
| Novartis | 7 | $187 |
| Fresenius USA Marketing, Inc. | 3 | $147 |
| Akebia Therapeutics Inc | 1 | $123 |
| Calliditas Therapeutics US Inc. | 5 | $108 |
| Bayer | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Boehringer Ingelheim | 3 | $75 |
| Mallinckrodt Hospital Products Inc. | 3 | $73 |
| Lilly USA, LLC | 3 | $63 |
| Nxstage Medical, Inc. | 2 | $36 |
| OPKO Pharmaceuticals, LLC | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Ardelyx, Inc. | 1 | $25 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Amgen | 1 | $21 |
| Sanofi | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,610 in reported general payments places this provider in the 75th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 22 | $5,170 |
| Hydralazine Hcl | 38 | $741 |
| Midodrine Hcl | 14 | $473 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $366 |
| Furosemide | 29 | $266 |
| Amlodipine Besylate | 58 | $266 |
| Calcitriol | 11 | $239 |
| Losartan Potassium | 15 | $121 |
| Clonidine Hcl | 18 | $89 |
| Carvedilol | 17 | $66 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Huntsville
- Joseph HolleyHuntsville$16K
- Chelsea HooverHuntsville$11K
- Marjorie CobbHuntsville$10K
- Sarah WilsonHuntsville$9K
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.